Nerdwallet Inc vs Philip Morris International Inc. — how do they compare? Nerdwallet Inc trades at $9.22 (market cap $603.70M), while Philip Morris International Inc. trades at $188.62 (market cap $300.37B). The key difference: Philip Morris International Inc. is far larger — about 497.5× Nerdwallet Inc's market cap, and Philip Morris International Inc. pays a 3.05% dividend while Nerdwallet Inc pays none. Which is the better fit depends on your goals.
| NRDS | PM | |
|---|---|---|
Market Cap | $603.70M | $300.37B |
Sector | Financials | Consumer Staples |
52-Week High | $15.93 | $192.98 |
52-Week Low | $7.58 | $144.33 |
Enterprise Value | $518.00M | $346.86B |
Dividend Yield | — | 3.05% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $192.98, up 1.65% today, near the analyst consensus price target of $194. The stock shows a bullish technical trend with strong moving average support. Fundamentally, the company reported robust 2025 results with revenue of $40.65 billion and net income of $11.35 billion, though recent news highlights a $500 million impairment charge and reduced profit guidance for 2026 due to cost pressures.
The outlook remains cautiously optimistic with 68% of analysts rating it a Buy, but investors face headwinds from currency volatility, rising illicit tobacco trade in Europe, and margin compression. The stock's valuation at a P/E of 27.13 appears full priced, requiring continued execution to justify further upside.
Trailing returns across standard periods
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →